CS
BIOTW

Clear Street’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Clear Street’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,861
Closed -$3K – 1502
2022
Q4 		$3K Sell
45,861
-418
-0.9% -$16 ﹤0.01% 805
2022
Q3 		$3K Hold
46,279
– – ﹤0.01% 922
2022
Q2 		$4K Buy
46,279
+30,428
+192% +$6.29K ﹤0.01% 775
2022
Q1 		$4K Buy
+15,851
New +$5.05K ﹤0.01% 343

Clear Street's BIOTW Position: Q1 2023 in Review

Clear Street sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 45,861 shares — an estimated $3K sold.

Clear Street first reported a position in BIOTW in Q1 2022 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • Clear Street reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • Clear Street sold 45,861 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $3K.
  • Clear Street first reported a position in Biotech Acquisition Company Warrant in Q1 2022 and held it in 4 quarters.
  • Clear Street's Biotech Acquisition Company Warrant position peaked at $4K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.